ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,77
-1,03%
Bitcoin
62 916,11
6,41%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Amylyx Pharmaceuticals Inc (AMLX)

  7. Amylyx Pharmaceuticals Inc (AMLX) Actualités

AMLX Amylyx Pharmaceuticals Inc

2,03
0,03 (1,50%)
Après les heures de négociation
Dernière mise à jour : 22:20:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Amylyx Pharmaceuticals Inc AMLX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,03 1,50% 2,03 22:20:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,05 2,00 2,13 2,04 2,00
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
02/5/202415:00BWAmylyx Pharmaceuticals to Report First Quarter 2024..
10/4/202415:00BWAmylyx Pharmaceuticals Announces Interim Data From Ongoing..
09/4/202411:45PRNUSThe Gross Law Firm Notifies Amylyx Pharmaceuticals, Inc...
08/4/202415:00BWAmylyx Pharmaceuticals to Host Virtual Webcast to Discuss..
05/4/202411:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
04/4/202413:00BWAmylyx Pharmaceuticals Announces Formal Intention to Remove..
02/4/202411:45PRNUSThe Gross Law Firm Reminds Amylyx Pharmaceuticals, Inc...
29/3/202410:45PRNUSThe Gross Law Firm Announces the Filing of a Securities..
26/3/202410:45PRNUSShareholders of Amylyx Pharmaceuticals, Inc. Should Contact..
25/3/202413:00PRNUSINVESTOR ALERT: AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX)..
22/3/202410:45PRNUSThe Gross Law Firm Notifies Shareholders of Amylyx..
19/3/202410:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
14/3/202414:00BWAmylyx Pharmaceuticals Appoints Bernhardt Zeiher, MD, FCCP,..
14/3/202410:50PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
11/3/202413:44EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11/3/202410:50PRNUSAmylyx Pharmaceuticals, Inc. Class Action: The Gross Law..
08/3/202413:10EDGAR2Form 8-K - Current report
08/3/202413:00BWAmylyx Pharmaceuticals Announces Topline Results From Global..
07/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202411:45PRNUSAmylyx Pharmaceuticals, Inc. Sued for Securities Law..
29/2/202400:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202400:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202423:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202411:45PRNUSAMLX LAWSUIT ALERT: The Gross Law Firm Notifies Amylyx..
23/2/202422:05BWAmylyx Pharmaceuticals Announces Inducement Grants Under..
22/2/202422:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202414:22EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202413:08EDGAR2Form 8-K - Current report
22/2/202413:00BWAmylyx Pharmaceuticals Reports Fourth Quarter and Full Year..
22/2/202411:45PRNUSAmylyx Pharmaceuticals, Inc. Class Action: The Gross Law..
15/2/202422:05BWAmylyx Pharmaceuticals to Report Fourth Quarter and Full..
15/2/202415:00BWAmylyx Pharmaceuticals to Present Updates on its AMX0114 and..
15/2/202411:00PRNUSLost Money on Amylyx Pharmaceuticals, Inc.(AMLX)? Join Class..
08/2/202415:00BWAmylyx Pharmaceuticals Announces Completion of Enrollment in..
11/1/202423:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202423:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/12/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202315:00BWAmylyx Pharmaceuticals Announces First Participant Dosed in..
19/12/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202313:00EDGAR2Form 8-K - Current report
04/12/202315:00BWAmylyx Pharmaceuticals Announces Publication of Data Showing..
29/11/202323:15BWAmylyx Pharmaceuticals Announces Inducement Grants Under..
28/11/202313:00BWAmylyx Pharmaceuticals Appoints Camille L. Bedrosian, MD, as..
27/11/202315:00BWRELYVRIO® and AMX0114 Data to be Presented at 34th..
21/11/202315:00BWAmylyx Pharmaceuticals to Participate at the 6th Annual..
21/11/202302:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202313:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Dernières Valeurs Consultées

NASDAQ
AMLX
Amylyx Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés